Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children (Q43177458)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2005

Language	Label	Description	Also known as
English	Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children	scientific article published in February 2005

Statements

scholarly article

1 reference

Europe PubMed Central

15 November 2017

Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children (English)

1 reference

Europe PubMed Central

15 November 2017

1 reference

based on heuristic

inferred from title

attenuated vaccine

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Pedro A Piedra

1

1 reference

Europe PubMed Central

15 November 2017

Manjusha J Gaglani

2

1 reference

Europe PubMed Central

15 November 2017

Claudia A Kozinetz

3

1 reference

Europe PubMed Central

15 November 2017

Gayla Herschler

4

1 reference

Europe PubMed Central

15 November 2017

Mark Riggs

5

1 reference

Europe PubMed Central

15 November 2017

Melissa Griffith

6

1 reference

Europe PubMed Central

15 November 2017

Charles Fewlass

7

1 reference

Europe PubMed Central

15 November 2017

Matt Watts

8

1 reference

Europe PubMed Central

15 November 2017

Colin Hessel

9

1 reference

Europe PubMed Central

15 November 2017

Julie Cordova

10

1 reference

Europe PubMed Central

15 November 2017

W Paul Glezen

11

1 reference

Europe PubMed Central

15 November 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

15 November 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

15 November 2017

23

1 reference

Europe PubMed Central

15 November 2017

1540-1548

1 reference

Europe PubMed Central

15 November 2017

13

1 reference

Europe PubMed Central

15 November 2017

Pandemic versus epidemic influenza mortality: a pattern of changing age distribution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Medical care capacity for influenza outbreaks, Los Angeles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Emerging infections: pandemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Influenza: its control in persons and populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Influenza and the rates of hospitalization for respiratory disease among infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

The impact of influenza in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Influenza-related hospitalizations among children in Hong Kong.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

The incidence of influenza-associated hospitalizations in children in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

The Japanese experience with vaccinating schoolchildren against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Invited commentary: Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Study designs for evaluating different efficacy and effectiveness aspects of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Estimating household and community transmission parameters for influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Modification of an Outbreak of Influenza in Tecumseh, Michigan by Vaccination of Schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.025

7 January 2021

Identifiers

10.1016/J.VACCINE.2004.09.025

1 reference

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

15 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43177458&oldid=1982977574"